190.00p+0.00 (+0.00%)12 Apr 2021, 14:02
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Immunodiagnostic Systems Holdings PLC Fundamentals

Company NameImmunodiagnostic Systems Holdings PLCLast Updated2021-04-12
IndustryMedical DevicesSectorHealthcare
Shares in Issue28.784 mMarket Cap£54.69 m
PE Ratio158.73Dividend per Share£0.01
Dividend Yield1Dividend Cover16.57
EPS£0.12EPS Growth (%)3.81
PEG0DPS Growth (%)-0.5882
Debt Ratio0.0545Debt Equity Ratio0.0526
Asset Equity Ratio1.2558Cash Equity Ratio0.4478
Quick Ratio3.6809Current Ratio5.40
Price To Book Value1.0131ROCE0

Immunodiagnostic Systems Holdings PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Immunodiagnostic Systems Holdings PLC Company Financials

Tangible Assets£9.81 m£6.85 m£7.47 m
Intangible Assets£11.16 m£11.18 m£10.99 m
Total Fixed Assets£21.37 m£18.38 m£19.19 m
Stocks£10.74 m£7.82 m£8.38 m
Debtors£10.35 m£9.18 m£8.15 m
Cash & Equivalents£27.58 m£27.71 m£28.53 m
Other Assets000
Total Assets£73.31 m£65.92 m£67.54 m
Creditors within 1 year£11.12 m£7.32 m£7.26 m
Creditors after 1 year£5.10 m£3.30 m£3.40 m
Other Liabilities000
Total Liabilities£16.22 m£10.62 m£10.67 m
Net assets£57.09 m£55.30 m£56.87 m
Called up share capital£589,000.00£589,000.00£589,000.00
Share Premium£32.34 m£32.34 m£32.34 m
Profit / Loss£3.25 m£842,000.00£935,000.00
Other Equity£57.09 m£55.30 m£56.87 m
Preference & Minorities000
Total Capital Employed£57.09 m£55.30 m£56.87 m
Debt Ratio£0.05£0.02£0.02
Assets / Equity1.25581.25581.2558
Cash / Equity0.44780.44780.4478
Cash Flow202020192018
Cash from operating activities£5.54 m£5.78 m£2.52 m
Cashflow before financing£4.61 m£3.76 m£1.11 m
Increase in Cash-£58,000.00-£665,000.00-£2.76 m
Turnover£39.35 m£38.51 m£37.95 m
Cost of sales£21.97 m£21.82 m£19.93 m
Gross Profit£17.38 m£16.70 m£18.01 m
Operating Profit£1.33 m£429,000.00£947,000.00
Pre-Tax profit£3.25 m£842,000.00£935,000.00

Immunodiagnostic Systems Holdings PLC Company Background

ActivitiesImmunodiagnostic Systems Holdings PLC is an in-vitro diagnostic (IVD) solution provider to the clinical laboratory market. It develops, manufacture, and market immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. The company's operating segment includes Automated IVD; Manual IVD and Technology. It generates maximum revenue from Automated IVD business segment. Geographically, it has a presence in Germany; France; the United States, and other countries.
Latest Interim Date20 Nov 2020
Latest Fiscal Year End Date17 Jun 2020

Immunodiagnostic Systems Holdings PLC Directors

2020-07-01Mr. Peter John Williamson
2015-06-29Dr. Patrik Olof DahlenChief Executive Officer
2020-07-01Dr. Burkhard WittekChairman
2012-03-30Mr. Paul HailesFinance Director & Company Secretary
2011-08-09Mr. David Eric EvansChairman
2019-06-27Mr Anthony WilksGroup Sales & Marketing
2012-08-10Mr Christopher Ian CooksonChief Executive Officer
2012-09-17Dr. Roger Thomas DugganDeputy Chairman
2013-06-21Dr. Martha Louise GarrityTechnical Director
2013-06-21Mr Alain RousseauEngineering Director
2016-06-22Mr. Chris Henry Francis YatesGroup Finance Director
2013-03-04Barry Kenneth HextallFinance Director(Interim)
2018-06-29Mr. Till Bengt Campe
2017-03-31Carlos Patricio Lacalle ZandoChief Executive Officer
2020-07-01Klaus Peter Kaspar
2020-07-01Paul James MartinChief Financial Officer & Company Secretary
2018-06-21 Regis Jacques Duval Chief Executive Officer
2020-07-01Mr. Jaap StuutChief Executive Officer

Immunodiagnostic Systems Holdings PLC Contact Details

Company NameImmunodiagnostic Systems Holdings PLC
Address10 Didcot Way, Boldon Business Park, Boldon, NE35 9PD
Telephone+44 1915190660

Immunodiagnostic Systems Holdings PLC Advisors

SolicitorMuckle LLP
Phone+44 1912324402
Fax+44 1912616954
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101
StockbrokerPeel Hunt LLP
Phone+44 2074188900
BankBarclays Bank PLC
Nominated AdviserPeel Hunt LLP
Phone+44 2074188900